Search

Your search keyword '"Larson, R"' showing total 382 results

Search Constraints

Start Over You searched for: Author "Larson, R" Remove constraint Author: "Larson, R" Publication Year Range Last 10 years Remove constraint Publication Year Range: Last 10 years
382 results on '"Larson, R"'

Search Results

1. Testing for Intrinsic Type Ia Supernova Luminosity Evolution at z>2 with JWST

2. COSMOS-Web: The Role of Galaxy Interactions and Disk Instabilities in Producing Starbursts at z<4

3. TREASUREHUNT: Transients and Variability Discovered with HST in the JWST North Ecliptic Pole Time Domain Field

5. CEERS Key Paper VI: JWST/MIRI Uncovers a Large Population of Obscured AGN at High Redshifts

6. An Ultra Deep Field survey with WFIRST

7. On the observability of individual Population III stars and their stellar-mass black hole accretion disks through cluster caustic transits

8. First observations of speed of light tracks by a fluorescence detector looking down on the atmosphere

9. An Ultra Deep Field survey with WFIRST

15. TREASUREHUNT: Transients and Variability Discovered with HST in the JWST North Ecliptic Pole Time-domain Field

16. Canine cell line, IPC‐366, as a good model for the study of inflammatory breast cancer

17. European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia

26. CEERS Key Paper. VI. JWST/MIRI Uncovers a Large Population of Obscured AGN at High Redshifts

27. CEERS Key Paper. VI. JWST/MIRI Uncovers a Large Population of Obscured AGN at High Redshifts

38. AML-464 Tolerability and efficacy of the first-in-class anti-CD47 antibody magrolimab combined with azacitidine in frontline patients with TP53-mutated acute myeloid leukemia (AML): Phase 1b results

39. MLL rearrangements impact outcome in HOXA-deregulated T-lineage acute lymphoblastic leukemia: a Children’s Oncology Group Study

45. Caution in using second generation tyrosine kinase inhibitor, especially for first line therapy of chronic myeloid leukemia

47. P1451: PRELIMINARY RESULTS FROM THE FLU/CY/ALEMTUZUMAB ARM OF THE PHASE I BALLI-01 TRIAL OF UCART22, AN ANTI-CD22 ALLOGENEIC CAR-T CELL PRODUCT, IN PATIENTS WITH RELAPSED/REFRACTORY (R/R) CD22+ B-CELL ALL

48. S132: TOLERABILITY AND EFFICACY OF THE FIRST-IN-CLASS ANTI-CD47 ANTIBODY MAGROLIMAB COMBINED WITH AZACITIDINE IN FRONTLINE PATIENTS WITH TP53-MUTATED ACUTE MYELOID LEUKEMIA: PHASE 1B RESULTS

49. Gene Editing/Gene Therapies: A SYNTHETIC CYTOKINE RECEPTOR PLATFORM FOR PRODUCING CYTOTOXIC INNATE LYMPHOCYTES AS “OFF-THE-SHELF” CANCER THERAPEUTICS

50. Prognostic and biologic significance of DNMT3B expression in older patients with cytogenetically normal primary acute myeloid leukemia

Catalog

Books, media, physical & digital resources